Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026)

Revolution Medicines' Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $70.4 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 9.6% year-over-year to $70.4 million in Q1 2026; TTM through Mar 2026 was $70.4 million, a 9.6% decrease from a year earlier, with the FY2025 full-year figure at $70.4 million, down 1.22% from the prior year.
• Goodwill & Intangibles steadied at $70.4 million in Q1 2026 per RVMD's latest filing, from $70.4 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $111.7 million in Q2 2024 and bottomed at $70.4 million in Q1 2023.
• The 5-year median for Goodwill & Intangibles is $72.6 million (2023), against an average of $75.3 million.
• Across the five-year window, Goodwill & Intangibles jumped 53.3% in 2024 and tumbled 36.68% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $73.4 million in 2022, then declined by 1.45% to $72.3 million in 2023, then decreased by 1.48% to $71.3 million in 2024, then slipped by 1.22% to $70.4 million in 2025, then changed by 0.0% to $70.4 million in 2026.
• Per Business Quant, the three latest RVMD Goodwill & Intangibles figures stand at $70.4 million (Q1 2026), $70.4 million (Q4 2025), and $77.9 million (Q3 2025).